Zobrazeno 1 - 10
of 22
pro vyhledávání: '"June Greenberg"'
Autor:
Farid Boulad, Tsiporah Shore, Koen van Besien, Caterina Minniti, Mihaela Barbu-Stevanovic, Sylvie Wiener Fedus, Fabiana Perna, June Greenberg, Danielle Guarneri, Vijay Nandi, Audrey Mauguen, Karina Yazdanbakhsh, Michel Sadelain, Patricia A. Shi
Publikováno v:
Haematologica, Vol 103, Iss 9 (2018)
Externí odkaz:
https://doaj.org/article/a176e8ed3c684be4b5a469a875cb1b47
Autor:
Adomah Opong, June Greenberg, Richard R. Furman, Adriana C Rossi, Michelle Pasciolla, Koen van Besien, Adrienne A. Phillips, Yuliya S. Jhanwar, Usama Gergis, Tsiporah B. Shore, Peter Martin, Tomer M Mark, John P. Leonard, Grace Suhu, Sarah C. Rutherford, Kathleen Maignan, Sebastian Mayer, Jessy Ryan, Danielle Guarneri, Roger N. Pearse, Calvin Koo, Jia Ruan, Maria Baldo, Jingmei Hsu, Edwidge Cuvilly, Nina Orfali
Publikováno v:
Leukemia & Lymphoma. 62:1629-1638
We evaluate the safety of bendamustine as a bridge to stem cell transplantation (SCT) in patients with relapsed/refractory lymphoma and residual disease after salvage therapy. Thirty-four subjects without complete responses (CR) received bendamustine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911dd92cb25b6dcea33d0a9bc249e096
https://doi.org/10.1080/10428194.2021.1881516
https://doi.org/10.1080/10428194.2021.1881516
Autor:
Sonia Elhadad, Amy Chadburn, Cynthia Magro, Koen Van Besien, Elisha D. O. Roberson, John P. Atkinson, Hunter Terry, June Greenberg, Whitney Reid, John Chapin, Dennis Copertino, Sahar Geramfard, Lizamarie Bachier Rodriguez, Nina Orfali, Usama Gerghis, Tsiporah Shore, Sebastian Mayer, Jasimuddin Ahamed, Jeffrey Laurence
Publikováno v:
Bone marrow transplantation. 57(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9374853d433aea48192b2ae46995b799
https://pubmed.ncbi.nlm.nih.gov/35661836
https://pubmed.ncbi.nlm.nih.gov/35661836
Autor:
Paul J. Christos, Morton Coleman, Tomer M Mark, June Greenberg, Ruben Niesvizky, Tsiporah B. Shore, Adriana C Rossi, Jingmei Hsu, Sebastian Mayer, Roger N. Pearse, Danielle Guarneri, Usama Gergis, Adrienne A. Phillips, Koen van Besien, Alexandra Gomez-Arteaga
Publikováno v:
Bone Marrow Transplantation. 54:2027-2038
High-dose melphalan (MEL200) followed by autologous stem cell transplantation (ASCT) remains a standard of care for multiple myeloma (MM). Bendamustine induces responses in MM resistant to other alkylators. Our prior Phase I trial adding bendamustine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb136d17c3b9c6cebb0c6f5d6a2fea21
https://doi.org/10.1038/s41409-019-0587-0
https://doi.org/10.1038/s41409-019-0587-0
Autor:
Daniel W. Sherbenou, Linda Tegnestam, Karen Pekle, Tsiporah B. Shore, Arthur Perry, David Jayabalan, Adriana C Rossi, Ruben Niesvizky, Scott Ely, Morton Coleman, Sebastian Mayer, Roger N. Pearse, Koen van Besien, Usama Gergis, Tomer M Mark, Danielle Guarneri, Peter A. Forsberg, June Greenberg
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(6)
Autologous stem cell transplantation (ASCT) conditioned with high-dose chemotherapy has long been established as the standard of care for eligible patients with newly diagnosed multiple myeloma. Despite recent therapeutic advances, high-dose melphala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa321bff80bfca3b0999599a18b0d38
https://pubmed.ncbi.nlm.nih.gov/28285081
https://pubmed.ncbi.nlm.nih.gov/28285081
Autor:
Stanley J. Goldsmith, John P. Leonard, Anca M. Avram, Rebecca Elstrom, Ryan Putman, Joseph R. Osborne, Jia Ruan, Daniel Lebovic, Kent A. Griffith, Peter Martin, Morton Coleman, Paul J. Christos, Erica Chapman, Richard R. Furman, June Greenberg, Madhu Mazumdar, Mark S. Kaminski
Publikováno v:
Leukemia & Lymphoma. 56:342-346
Radioimmunotherapy (RIT) is effective treatment for indolent non-Hodgkin lymphomas (NHLs), but response durations are usually limited, especially in aggressive NHL. We hypothesized that administration of bortezomib as a radiosensitizer with RIT would
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f446d4bb399f68a8500b9e0254e508
https://doi.org/10.3109/10428194.2014.914195
https://doi.org/10.3109/10428194.2014.914195
Autor:
Usama Gergis, Tsiporah B. Shore, June Greenberg, Koen van Besien, Morton Coleman, Ruben Niesvizky, Tomer M Mark, Sebastian Mayer, Roger N. Pearse, Whitney Reid
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:831-837
Bendamustine has efficacy in multiple myeloma with a toxicity profile limited to myelosuppression. We hypothesized that adding bendamustine to autologous stem cell transplant conditioning in myeloma would enhance response without significant addition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8f4d12e42e0fd00915942a210d4954
https://doi.org/10.1016/j.bbmt.2013.02.013
https://doi.org/10.1016/j.bbmt.2013.02.013
Autor:
Danielle Guarneri, Koen van Besien, Michel Sadelain, Sylvie wiener Fedus, Fabiana Perna, Tsiporah B. Shore, Farid Boulad, Patricia A. Shi, Mihaela Barbu-Stevanovic, Caterina P. Minniti, June Greenberg, Audrey Mauguen, Vijay Nandi, Karina Yazdanbakhsh
Publikováno v:
Haematologica
Gene therapy for sickle cell disease is limited by the yield of hematopoietic progenitor cells that can be harvested for transduction or gene editing. We therefore performed a phase I dose-escalation study of the hematopoietic progenitor cell mobiliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145aeed8505bf688643cb6eea7f74253
https://doi.org/10.3324/haematol.2018.199414
https://doi.org/10.3324/haematol.2018.199414
Autor:
Farid Boulad, Karina Yazdanbakhsh, Caterina P. Minniti, Petra Pham, Tsiporah B. Shore, Mohandas Narla, Mihaela Barbu-Stevanovic, Patricia A. Shi, June Greenberg, Beau Mitchell, Michel Sadelain, Danielle Guarneri
Publikováno v:
Blood. 130:963-963
Background: Increased baseline white blood cell count (WBC) has been associated with vaso-occlusive complications in sickle cell disease (SCD), raising concern for the use of mobilizing agents that increase WBC count for hematopoietic progenitor cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd8c13af3f6646b628e7fbed837d22d0
https://doi.org/10.1182/blood.v130.suppl_1.963.963
https://doi.org/10.1182/blood.v130.suppl_1.963.963
Autor:
Stanley J. Goldsmith, Morton Coleman, Scott Ely, June Greenberg, John P. Leonard, Peter Martin, Richard R. Furman, Jia Ruan, Sarah C. Rutherford
Publikováno v:
Leukemialymphoma. 56(11)
Milatuzumab (hLL1), a humanized anti-CD74 monoclonal antibody, has activity in preclinical non-Hodgkin lymphoma (NHL) models. We conducted a phase 1 trial in previously treated B-cell malignancies. Dose escalation included four planned dose levels (1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec7545251e667f4e06a218484733753
https://pubmed.ncbi.nlm.nih.gov/25754579
https://pubmed.ncbi.nlm.nih.gov/25754579